Frank C. Sciurba
Elite in Chronic Obstructive Pulmonary Disease (COPD)

Dr. Frank C. Sciurba

Pulmonary Medicine
UPMC
UPMC Comprehensive Lung Center - Falk
3601 5th Avenue, Floor 4, 
Pittsburgh, PA 
On Staff At
Accepting New Patients
Offers Telehealth

Elite in Chronic Obstructive Pulmonary Disease (COPD)
UPMC
UPMC Comprehensive Lung Center - Falk
3601 5th Avenue, Floor 4, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Frank Sciurba, MD, specializes in pulmonology and is certified by the American Board of Internal Medicine. He practices at UPMC Presbyterian and is affiliated with University of Pittsburgh Physicians, Department of Medicine. Dr. Sciurba completed his fellowship at the University of Pittsburgh School of Medicine and medical degree at the University of Chicago. Dr. Sciurba specializes in treating patients with emphysema and chronic obstructive pulmonary disease (COPD). Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule.

Dr. Sciurba is rated as an Elite provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Long Haul COVID, Idiopathic Pulmonary Fibrosis, and Endoscopy.

His clinical research consists of co-authoring 219 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 165 articles and participated in 12 clinical trials in the study of Chronic Obstructive Pulmonary Disease (COPD).

Specialties
Pulmonary Medicine
Licenses
Specialist in PA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
University of Pittsburgh School of Medicine
Hospital Affiliations
Upmc Presbyterian Shadyside
Upmc Passavant
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UPMC Comprehensive Lung Center - Falk
3601 5th Avenue, Floor 4, Pittsburgh, PA 15213
Call: 412-530-6117

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Enrollment Status: Active_not_recruiting
Publish Date: December 16, 2025
Intervention Type: Drug
Study Drugs: Roflumilast, Azithromycin
Study Phase: Phase 4
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)
Enrollment Status: Active_not_recruiting
Publish Date: September 17, 2025
Zephyr Valve Registry
Zephyr Valve Registry
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Device
An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction
An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Other
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
Enrollment Status: Unknown
Publish Date: June 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States
A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States
Enrollment Status: Unknown
Publish Date: May 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)
Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)
Enrollment Status: Terminated
Publish Date: February 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Enrollment Status: Terminated
Publish Date: January 25, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
The Use of High Frequency Oscillations With Noninvasive Ventilation (NIV) in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Participants
The Use of High Frequency Oscillations With Noninvasive Ventilation (NIV) in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Participants
Enrollment Status: Terminated
Publish Date: May 06, 2019
Intervention Type: Device
Study Phase: Not Applicable
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Enrollment Status: Completed
Publish Date: March 08, 2019
Intervention Type: Procedure
View 12 Less Clinical Trials

219 Total Publications

Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD Trial.
Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD Trial.
Journal: Annals of the American Thoracic Society
Published: October 24, 2025
View All 219 Publications
Similar Doctors
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Dr. Brijinder S. Kochhar
Pulmonary Medicine
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Dr. Brijinder S. Kochhar
Pulmonary Medicine
100 Welday Ave, Suite C, 
Wintersville, OH 
 (39.3 miles away)
740-264-2803
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brijinder Kochhar is a Pulmonary Medicine provider in Wintersville, Ohio. Dr. Kochhar is rated as a Distinguished provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Atypical Pneumonia, Advanced Bronchoscopy, and Gastrostomy. Dr. Kochhar is currently accepting new patients.

Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Dr. Melvin T. Saludes
Pulmonary Medicine
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Dr. Melvin T. Saludes
Pulmonary Medicine
426 8th St, Suite 305, 
Glen Dale, WV 
 (54.3 miles away)
304-843-5041
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Melvin Saludes is a Pulmonary Medicine provider in Glen Dale, West Virginia. Dr. Saludes is rated as a Distinguished provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Hospital-Acquired Pneumonia, Gastrostomy, and Advanced Bronchoscopy. Dr. Saludes is currently accepting new patients.

Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Dr. Ramesh Kaul
Pulmonary Medicine | Sleep Medicine
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Dr. Ramesh Kaul
Pulmonary Medicine | Sleep Medicine

Lifeline Centers PC

2602 Wilmington Rd, Suite 204, 
New Castle, PA 
 (45.7 miles away)
412-351-6545
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ramesh Kaul is a Pulmonary Medicine specialist and a Sleep Medicine provider in New Castle, Pennsylvania. Dr. Kaul is rated as a Distinguished provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Gastrostomy, and Pacemaker Implantation.

VIEW MORE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sciurba's expertise for a condition
ConditionClose
  • Elite
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Sciurba is
    Elite
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Emphysema
    Dr. Sciurba is
    Elite
    . Learn about Emphysema.
    See more Emphysema experts
  • Distinguished
  • Acute Interstitial Pneumonia
    Dr. Sciurba is
    Distinguished
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Bronchitis
    Dr. Sciurba is
    Distinguished
    . Learn about Bronchitis.
    See more Bronchitis experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Sciurba is
    Distinguished
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
  • Interstitial Lung Disease
    Dr. Sciurba is
    Distinguished
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Long Haul COVID
    Dr. Sciurba is
    Distinguished
    . Learn about Long Haul COVID.
    See more Long Haul COVID experts
  • Pulmonary Fibrosis
    Dr. Sciurba is
    Distinguished
    . Learn about Pulmonary Fibrosis.
    See more Pulmonary Fibrosis experts
  • Advanced
  • Bullae
    Dr. Sciurba is
    Advanced
    . Learn about Bullae.
    See more Bullae experts
  • Experienced
  • Alpha-1 Antitrypsin Deficiency (AATD)
    Dr. Sciurba is
    Experienced
    . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
    See more Alpha-1 Antitrypsin Deficiency (AATD) experts
  • Asthma
    Dr. Sciurba is
    Experienced
    . Learn about Asthma.
    See more Asthma experts
  • Bronchiectasis
    Dr. Sciurba is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Cerebral Hypoxia
    Dr. Sciurba is
    Experienced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • COVID-19
    Dr. Sciurba is
    Experienced
    . Learn about COVID-19.
    See more COVID-19 experts
  • Endoscopy
    Dr. Sciurba is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.